Stock comparison
IDEXX Laboratories
Waters
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
IDXX
IDEXX Laboratories
Market cap
$44.12B
Sector
Healthcare
WAT
Waters
Market cap
$22.32B
Sector
Healthcare
Overall winner
IDEXX Laboratories IDXX
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | IDXX | WAT | Winner |
|---|---|---|---|
| Warren Buffett | 75B | 63C | IDXX |
| Benjamin Graham | 80A | 62C | IDXX |
| Philip Fisher |
Side-by-side metrics
| Metric | IDXX | WAT |
|---|---|---|
| Market cap | $44.12B | $22.32B |
| P/E (TTM) | 39.0x | 63.6x |
| EV/EBIT | 31.6x | 30.7x |
| ROIC (TTM) | 40.66% | 2.25% |
| Gross margin | 62.05% | 55.02% |
| Net margin | 24.63% | 11.91% |
| Revenue CAGR 5y | 7.56% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
IDXX leads on
- EPS CAGR 5y10.79%vs -1.02%+109%
- ROIC (TTM)40.66%vs 2.25%+94%
- Revenue CAGR 5y7.56%vs 3.24%+57%
- Net margin24.63%vs 11.91%
More like WAT
Related on invest-like
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.